订阅小程序
旧版功能
研究兴趣

论文共 20 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
First-line Crizotinib Versus Chemotherapy in ALK-positive Lung Cancer
Benjamin J. Solomon,Tony Mok,Dong-Wan Kim,Yi-Long Wu,Kazuhiko Nakagawa,Tarek Mekhail,Enriqueta Felip,Federico Cappuzzo,Jolanda Paolini,Tiziana Usari,Shrividya Iyer,Arlene Reisman,Keith D. Wilner,Jennifer Tursi,Fiona Blackhall,M. Boyer,V. Ganju,B. Hughes,N. Pavlakis,B. Solomon, S. Varma, T. Berghmans,J-L Canon,I. Demedts, A. Janssens, R. Louis,T. Pieters,D. Schallier,V. Surmont, C. Maciel da Silva, C-G Moreira Ferreira,V. Hirsh, A. Joy,F. Laberge,W. Morzycki,R. Wierzbicki,B. Han, X. Liu,S. Qin, Y. Shi, Y. Wang,G. Wu,Y-L Wu, C. Zhou, J. Ahvonen,F. Barlesi,J. Cadranel,E. Dansin,J. Fayette, J-F Morere,D. Moro-Sibilot,J-L Pujol,E. Quoix,G. Zalcman, N. Frickhofen, C-P Schneider,T. Wehler,T. Mok,P. So,S. Cuffe,A. Bearz, C. Boni,F. Cappuzzo,F. Cognetti,F. De Braud,T. De Pas,D. Galetta,M. Migliorino,D. Rocco,G. Scagliotti, P. Tagliaferri,M. Tiseo, K. Aoe,T. Hida, T. Kato,T. Kozuki,K. Nakagawa, S. Niho,M. Nishio,H. Nokihara,M. Satouchi,T. Seto, T. Takahashi,J-S Ahn,D-W Kim,S-W Kim,G. Berchem, O. Arrieta Rodriguez,B. Biesma,A-M Dingemans,E. Smit, A. Helland,F. Barata,V. Gorbunova,G. Manikhas,S. Orlov, S. Leong,H-L Lim,R. Soo,E-H Tan, A. Nosworthy, M. Codes Villena,E. Felip,P. Garrido Lopez,D. Isla Casado,N. Martinez Banaclocha,S. Ponce Aix,N. Reguart Aransay,D. Rodriguez Abreu,J. Trigo Perez,O. Gautschi,M. Pless,A. Zippelius,G-C Chang, Y-H Tsai,Y. Shparyk,F. Blackhall,N. Steele, V. Armenio,K. Dragnev, M. Dugan,S. Gadgeel,D. Gerber, S. Graziano,S. Gurubhagavatula,L. Horn, S. Jalal, R. Lauer,R. Mehra,T. Mekhail, H. Mirshahidi, S. Pakkala,J. Polikoff,H. Raftopoulos, M. Saleh,R. Salgia,S. Waqar
New England Journal of Medicine（2014）
引用3796浏览0WOS引用
3796
0
加载更多
作者统计

#Papers: 20

#Citation: 3851

H-Index: 4

G-Index: 9

Sociability: 5

Diversity: 2

Activity: 1

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn